|
1
|
Dadan J, Wojskowicz P and Wojskowicz A:
Neuroendocrine tumors of the pancreas. Wiad Lek. 61:43–47.
2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hirshberg B, Cochran C, Skarulis MC,
Libutti SK, Alexander HR, Wood BJ, Chang R, Kleiner DE and Gorden
P: Malignant insulinoma: Spectrum of unusual clinical features.
Cancer. 104:264–272. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kamocki ZK, Wodynska NA and Pryczynicz A:
Co-existence of insulinoma and diabetes: A case report. Oncol Lett.
8:1697–1700. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Doherty GM, Doppman JL, Shawker TH, Miller
DL, Eastman RC, Gorden P and Norton JA: Results of a prospective
strategy to diagnose, localize, and resect insulinomas. Surgery.
110:989–997. 1991.PubMed/NCBI
|
|
5
|
Lablanche S, Chobert-Bakouline M, Risse O,
Laverriere MH, Chabre O and Benhamou PY: Malignant insulinoma may
arise during the course of type 1 diabetes mellitus: A case report.
Diabetes Metab. 41:258–261. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jonkers YM, Ramaekers FC and Speel EJ:
Molecular alterations during insulinoma tumorigenesis. Biochim
Biophys Acta. 1775:313–332. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhan HX, Cong L, Zhao YP, Zhang TP, Chen
G, Zhou L and Guo JC: Activated mTOR/P70S6K signaling pathway is
involved in insulinoma tumorigenesis. J Surg Oncol. 106:972–980.
2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bhatti TR, Ganapathy K, Huppmann AR,
Conlin L, Boodhansingh KE, MacMullen C, Becker S, Ernst LM, Adzick
NS, Ruchelli ED, et al: Histologic and molecular profile of
pediatric insulinomas: Evidence of a paternal Parent-of-Origin
effect. J Clin Endocrinol Metab. 101:914–922. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pavelic K, Hrascan R, Kapitanovic S,
Vranes Z, Cabrijan T, Spaventi S, Korsic M, Krizanac S, Li YQ,
Stambrook P, et al: Molecular genetics of malignant insulinoma.
Anticancer Res. 16:1707–1717. 1996.PubMed/NCBI
|
|
10
|
Huang YT, Lan Q, Ponsonnet L, Blanquet M,
Christofori G, Zaric J and Rüegg C: The matricellular protein CYR61
interferes with normal pancreatic islets architecture and promotes
pancreatic neuroendocrine tumor progression. Oncotarget.
7:1663–1674. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Heitz PU, Kasper M, Polak JM and Klöppel
G: Pancreatic endocrine tumors. Hum Pathol. 13:263–271.
1982.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sakurai A, Aizawa T, Katakura M, Sato Y,
Kaneko G, Yoshizawa K and Hashizume K: Insulinoma in a patient with
non-insulin-dependent diabetes mellitus. Endocr J. 44:473–477.
1997.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Weir GC and Bonner-Weir S: Islet β cell
mass in diabetes and how it relates to function, birth, and death.
Ann N Y Acad Sci. 1281:92–105. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ouyang D, Dhall D and Yu R: Pathologic
pancreatic endocrine cell hyperplasia. World J Gastroenterol.
17:137–143. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Stefanovski D, Richey JM, Woolcott O,
Lottati M, Zheng D, Harrison LN, Ionut V, Kim SP, Hsu I and Bergman
RN: Consistency of the disposition index in the face of diet
induced insulin resistance: Potential role of FFA. PLoS One.
6(e18134)2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cerf ME: Beta cell dysfunction and insulin
resistance. Front Endocrinol (Lausanne). 4(37)2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zumkeller W: Nesidioblastosis. Endocr
Relat Cancer. 6:421–428. 1999.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gotz W, Schucht C, Roth J, Theuring F and
Herken R: Endocrine pancreatic tumors in MSV-SV40 large T
transgenic mice. Am J Pathol. 142:1493–1503. 1993.PubMed/NCBI
|
|
19
|
Weir GC: Non-insulin-dependent diabetes
mellitus: Interplay between B-cell inadequacy and insulin
resistance. Am J Med. 73:461–464. 1982.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gjelberg HK, Hoem D, Verbeke CS, Eide J,
Cooper JG and Molven A: Hypoglycemia and decreased insulin
requirement caused by malignant insulinoma in a type 1 diabetic
patient: When the hoof beats are from a zebra, not a horse. Clin
Case Rep. 5:761–768. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Oikawa Y, Katsuki T, Kawasaki M,
Hashiguchi A, Mukai K, Handa K, Tomita M, Kabeya Y, Asai Y, Iwase
K, et al: Insulinoma may mask the existence of type 1 diabetes.
Diabet Med. 29:e138–e141. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Svartberg J, Stridsberg M, Wilander E,
Andersson DE and Eriksson B: Tumour-induced hypoglycaemia in a
patient with insulin-dependent diabetes mellitus. J Intern Med.
239:181–185. 1996.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Abbasakoor NO, Healy ML, O'Shea D, Maguire
D, Muldoon C, Sheahan K and O'Toole D: Metastatic insulinoma in a
patient with type 2 diabetes mellitus: Case report and review of
the literature. Int J Endocrinol. 2011(124078)2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ademoglu E, Unluturk U, Agbaht K, Karabork
A and Corapcioglu D: Type 2 diabetes mellitus in a patient with
malignant insulinoma manifesting following surgery. Diabet Med.
29:e133–e137. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Atkinson AB, Buchanan KD, Carson DJ,
Kennedy T, O'Hare MM, Sloan JM and Hadden DR: Insulinoma (apud cell
carcinoma) in a diabetic. Br Med J. 2:1397–1398. 1978.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Campos-Olive N, Ferrer-García JC and
Safont M: Malignant insulinoma in a patient with type 2 diabetes
mellitus. Acta Endo Buc. 6:103–109. 2010. View Article : Google Scholar
|
|
27
|
Ferrer-Garcia JC, Tolosa-Torrens M,
Hernando-Melia C, Arribas-Palomar L and Sanchez-Juan C: Everolimus
resolving hypoglycemia, producing hyperglycemia, and necessitating
insulin use in a patient with diabetes and nonresectable malignant
insulinoma. Endocr Pract. 17:e17–e20. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Grycewicz J, Scibor Z, Cwikla JB, Lewinski
A and Cypryk K: Recurrent hypoglycaemia in a type 2 diabetes
patient-diagnostic difficulties. Arch Med Sci. 6:126–129.
2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Holstein A, Morgenstern T, Dienst H and
Hiller W: Insulinoma as rare cause of severe post-partum
hypoglycemia. J Obstet Gynaecol Res. 41:1848–1850. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Podzolkov VI, Dragomiretskaia NA, Koroleva
TV, Kavtaradze NN, Iakovleva HH and Podzolkov AV: A rare case of
hypoglycemia in an elderly patient with type 2 diabetes mellitus:
Malignant metastasizing insulinoma. Klin Med (Mosk). 92:65–70.
2014.(In Russian). PubMed/NCBI
|
|
31
|
Schmitt J, Boullu-Sanchis S, Moreau F,
Drui S, Louis B, Chabrier G, Pinget M and Jeandidier N: Association
of malignant insulinoma and type 2 diabetes mellitus: A case
report. Ann Endocrinol (Paris). 69:69–72. 2008.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Siraj ES, Samuel G, Saber S, Samuel S,
Hamrahian AH and Reddy SS: Metastatic malignant insulinoma in a
patient with type 2 diabetes mellitus: Case presentation and
literature review. Endocr Pract. 12:411–416. 2006.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lei WY, Wang TE, Chen TL, Chang WH, Yang
TL and Wang CY: Insulinoma causing hypoglycemia in a patient with
type 2 diabetes. J Formos Med Assoc. 106:392–396. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Madathil A and Weaver J: Insulinoma
presenting as postprandial hypoglycaemia. BMJ Case Rep.
2011:2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Shimizu M, Suzuki K, Tsuchida K, Kojima M,
Hiraishi H and Aso Y: Insulinoma in a patient with chronic renal
failure due to type 2 diabetes mellitus treated effectively with
diazoxide. Intern Med. 54:621–625. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wildbrett J, Nagel M, Theissig F, Gaertner
HJ, Gromeier S, Fischer S and Hanefeld M: An unusual picture of
insulinoma in type-2 diabetes mellitus and morbid obesity. Dtsch
Med Wochenschr. 124:248–252. 1999.(In German). PubMed/NCBI View Article : Google Scholar
|
|
37
|
Iglesias P and Diez JJ: Management of
endocrine disease: A clinical update on tumor-induced hypoglycemia.
Eur J Endocrinol. 170:R147–R157. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Levine RA and Sobel BE: Insulinoma, type 2
diabetes and plasminogen activator inhibitor type-I. Coron Artery
Dis. 12:333–336. 2001.PubMed/NCBI View Article : Google Scholar
|
